News

Questions? Please ask the press team.

To press contacs
All news
Corporate
Brands
Sports
R&D

Scientific publication confirms Germany’s initial clinical study on COVID-19 patients: Viral load is reduced by using mouth and throat rinse

Read more
27.05.2021

Scientific publication confirms Germany’s initial clinical study on COVID-19 patients: Viral load is reduced by using mouth and throat rinse

Hospital hygiene experts have seen a connection between medical cleaning of the mouth and throat area and the reduction of ingested viral loads and other transmissions for quite some time. Initial laboratory data, specifically on COVID-19, have been known since autumn of 2020, but clinical results were still pending. These have now been published.

Read more

Still on course and defying the crisis with an enormous effort

Read more
22.04.2021

Still on course and defying the crisis with an enormous effort

In 2020, Bielefeld-based Dr. Wolff Group recorded a turnover of 341.1 million euros (2019: 313.4 million euros), an increase of about nine percent, with exports continuing to account for more than 20 percent.

Read more

Alcina hair division and caring cosmetics ensure stable sales

Read more

Alcina hair division and caring cosmetics ensure stable sales

In 2020, Bielefeld-based Dr. Wolff Group recorded an increase of almost nine percent with sales of 341.1 million euros (2019: 313.4 million). With 40.9 million euros in revenue (2019: 44.1 million) Alcina contributed a 12 per cent share to the group's total revenue in 2020.

Read more

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

Read more
13.04.2021

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

Promising German-Spanish partnership between Dr. August Wolff GmbH & Co. KG Arzneimittel and Cantabria Labs officially sealed.

Read more

Dr. August Wolff Submits Application for Marketing Authorization of 1% Glycopyrronium Bromide (GPB) Cream in the EU – Positive Phase 3a Part of Pivotal Study Results for 1% GPB Cream in Patients with Primary Axillary Hyperhidrosis

Read more
22.03.2021

Dr. August Wolff Submits Application for Marketing Authorization of 1% Glycopyrronium Bromide (GPB) Cream in the EU – Positive Phase 3a Part of Pivotal Study Results for 1% GPB Cream in Patients with Primary Axillary Hyperhidrosis

The Bielefeld-based family-owned pharmaceutical developing and manufacturing company Dr. August Wolff GmbH & Co. KG Arzneimittel (“Dr. August Wolff”) announces that the “Marketing Authorisation Application” (MAA) for 1% Glycopyrronium bromide (GPB) cream was submitted on February 26th to the Medical Products Agency (MPA, Sweden) despite the challenges of the COVID-19 pandemic.

Read more

First medical anti-COVID-19 mouth and throat wash with laboratory and clinical data

Read more
25.02.2021

First medical anti-COVID-19 mouth and throat wash with laboratory and clinical data

Based on their know-how in the field of oral hygiene, Dr. Wolff presents with Linola® sept mouth and throat wash for the first time a product, which has been confirmed in its effectivness against the corona virus in several laboratory and additional clinical test results.

Read more